Two large-scale phase III trials have found that Bayer’s elinzanetant can safely and effectively reduce hot flashes, paving the road to FDA approval.
Related Posts
As summer approaches and leases start to end, moving season…
Although the handheld gaming PC market doesn’t necessarily need an…
NASA is working to resolve a lingering issue with the…